NRC Health Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NRC Health payments for repurchase of common stock for the quarter ending 2026-06-30 was $7.64M, a 27.60% increase year-over-year.
- NRC Health payments for repurchase of common stock for the quarter ending 2026-03-31 was $1.94M, a 60.67% decline year-over-year.
- NRC Health payments for repurchase of common stock for the quarter ending 2025-12-31 was $1.00K, a 99.99% decline year-over-year.
- NRC Health payments for repurchase of common stock for the quarter ending 2025-09-30 was $9.27M, a 8.42% increase year-over-year.
- NRC Health payments for repurchase of common stock for fiscal 2025 was $20.18M, a 34.79% decline from fiscal 2024.
- NRC Health payments for repurchase of common stock for fiscal 2024 was $30.95M, a 62.02% increase from fiscal 2023.
- NRC Health payments for repurchase of common stock for fiscal 2023 was $19.10M, a 30.84% decline from fiscal 2022.
- NRC Health payments for repurchase of common stock for fiscal 2022 was $27.62M, a 566.73% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $7.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $18.85M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.94M 10-Q · filed 2026-05-06 | $17.20M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $20.18M 10-K · filed 2026-03-05 |
| 2025-09-30 | $9.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $27.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $26.86M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.92M 10-Q · filed 2026-05-06 | $20.87M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $30.95M 10-K · filed 2026-03-05 |
| 2024-09-30 | $8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $38.55M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $30.31M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $15.00M 10-Q · filed 2025-05-09 | $32.13M derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $19.10M 10-K · filed 2026-03-05 |
| 2023-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.42M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.25M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $1.97M 10-Q · filed 2024-05-09 | $22.91M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $27.62M 10-K · filed 2025-03-17 |
| 2022-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-06-30 | $15.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | |
| 2022-03-31 | $6.68M 10-Q · filed 2023-05-05 | |
| 2021-12-31 | $4.14M 10-K · filed 2024-02-27 | |
| 2015-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.67M 10-K · filed 2018-03-14 |
| 2015-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $399.00K 10-K · filed 2013-03-01 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | |
| 2009-12-31 | $84.00K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |